Posts

FreeMind Group is proud to support BioFIT 2017!

Where: Strasbourg, France
When: November 28-29, 2017

As you may know, the 6th edition of BioFIT will take place on 28th and 29th November in Strasbourg. BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations, early-stage innovation and seed investment in the field of Life Sciences. With more than 1,200 international leading actors from 35+ countries, the event gathers big pharma, emerging and small biotech companies, pre-seed/seed/Series A investors, as well as professionals from tech transfer, academia and research institutions.

Many key players have already confirmed their presence, including Pfizer, AbbVie, J&J, Sanofi, Roche, GSK, Novo Nordisk, Pierre Fabre, AstraZeneca, Lilly, Bayer, Merck, Servier, Janssen Pharmaceutica, Evotec, Lonza, Ipsen, Boehringer Ingelheim, Genfit, Transgene, Sofinnova Partners, Onxeo, Debiopharm, Kurma Partners, VIB, Novo Seeds, European Investment Fund, Max Planck Institute, MRC Technology, Ascenion, Isis Innovation…

Discover the list of participants
Download the programme

Use our network code BF17_FREEMINDS% for a 25% discount!


Register for BioFIT

Ayal Ronen, FreeMind’s Vice President, will be visiting the Research Triangle Park in North Carolina in late July and will be presenting at the NC Biotechnology Center‘s Hamner Conference Center on July 22.

Ayal will provide insight into the non-dilutive funding landscape with an emphasis on the NIH, DOD, and BARDA and will describe the various mechanisms and pockets of money available, potential for funding, and means to maximize chances for award.

There will also be an opportunity to meet with Ayal following the presentation where you can speak more directly about your specific organization and its funding needs. To schedule a 1×1, please email Irina.

This presentation is free and open to all, but registration is required.

Register here

View Agenda

Join Director of Business Development, Meytal Waiss, for a Lunch n Learn presentation on June 27th at the PA Biotechnology Center in Doylestown, PA, supported by the Baruch S. Blumberg Institute.

Come hear Meytal provide insight into the non-dilutive funding landscape with an emphasis on the NIH, DOD, and BARDA, as she describes the various mechanisms and pockets of money available, potential for funding, means to maximize chances for award, and a special funding assistance for Pennsylvania organizations applying for SBIR/STTR grants.

Lunch will be provided and attendance is free, but registration is required.

Register here

Lunch n Learn Agenda